Funding Rounds
Cardior Pharmaceuticals

Cardior Pharmaceuticals Series B round, August 2021

Cardior Pharmaceuticals

Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $75.30M

Raised Date: 2021-08-25

Investors